JOIN OUR SECOND CLINICAL TRIAL – Recruiting participants January 2025
Following the successful completion of our first clinical trial, Alyra Biotech is now looking to enrol a further 90 women to test the Alyra Device.
You can apply for the trial by clicking the link below, or scanning the QR code.
Who is eligible to join the trial?
This trial welcomes a wider range of women to join. It will include women with or without endometriosis – and with or without children. This means that even if you were not eligible to join the first trial, you will probably be eligible to join the second trial. We look forward to hearing from you.
All participants will be required to:
- Live in Adelaide
- Be aged between 18 – 45 years of age
- Experience pain with periods
- Be able to attend 6 onsite visits to the PARC clinical trials unit at the Royal Adelaide Hospital over 4 months
- Be willing to take 10 minutes every day for 4 months recording their symptoms on the custom Alyra APP
- Have not had an intrauterine device (IUD) in their uterus during the last 60 days
More about the trial:
Every woman’s individual situation is different. Once we receive your contact details we will contact you to hear more about your pain, and answer any questions that you have regarding the trial.
Participants who complete the trial will be paid an honorarium of $1200, receive a high quality ultrasound scan, and be provided with an educational pelvic pain resource at the end of the trial.
They will also have the excitement of contributing to a new area in women’s health that aims to provide new options for difficult to manage pain symptoms.
If you would like to find out more about the trial, and whether you may be eligible to join the trial, please scan the QR code below or use the following link to fill in a quick eligibility survey:
Or Click Here to complete the survey.
Your medical care during the trial will be provided by a specialist gynaecologists, and study participation is voluntary.
HOW IS THIS TRIAL DIFFERENT FROM OUR FIRST CLINICAL TRIAL? – Completed 2024
In 2024, Alyra Biotech successfully completed our first human trial of the Alyra device in Adelaide, Australia. Because this was a first-in-human trial, only a small number of the many women who applied to join the trial were eligible, and each woman was required to visit the trial centre on several occasions. However, following the success of the first trial, we now have Ethics Approval to offer simpler trial involvement to a wider group of women, including women who have not yet had a baby, or are on a wide range of medications. If you applied for the first trial but were not eligible to join the trial, it is quite possible that you are suitable for our second trial. We invite you to consider enrolling in our second trial.
